During the past decade, Beijing Tsinghua Chang Gung Memorial Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Beijing Tsinghua Chang Gung Memorial Hospital" are "Cholangiocarcinoma" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Beijing Tsinghua Chang Gung Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Tsinghua Chang Gung Memorial Hospital" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Chiglitazar 32mg" (1 trials), "Chiglitazar 48mg" (1 trials), "E7090" (1 trials), "Metformin Hydrochloride" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Tsinghua Chang Gung Memorial Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Beijing Tsinghua Chang Gung Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Beijing Tsinghua Chang Gung Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Tsinghua Chang Gung Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".